180
Participants
Start Date
April 14, 2021
Primary Completion Date
December 31, 2026
Study Completion Date
March 30, 2027
IDE397
IDE397 dosed orally
Docetaxel
Intravenous infusion
Paclitaxel
Intravenous infusion
Sacituzumab govitecan
Intravenous infusion
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
National Cheng Kung University Hospital, Tainan City
RECRUITING
Columbia University Medical Center - Herbert Irving Pavilion, New York
RECRUITING
Weill Cornell Medical College, New York
RECRUITING
National Cancer Center, Goyang-si
RECRUITING
Hôpital Timone, Marseille
RECRUITING
Universitaetsklinikum Hamburg-Eppendorf (UKE), Hamburg
RECRUITING
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RECRUITING
Hospital Universitario 12 de Octubre (H12O), Madrid
RECRUITING
START Madrid-HM - Centro Integral Oncológico Clara Campal (CIOCC), Madrid
RECRUITING
NEXT Madrid, Universitary Hospital QuironSAlud, Madrid
RECRUITING
CHA University - Bundang Medical Center, Seongnam-si
RECRUITING
Chungbuk National University Hospital, Cheongju-si
RECRUITING
Institut Claudius Regaud - IUCT-Oncopole, Toulouse
RECRUITING
Orlando Health Cancer Institute, Orlando
RECRUITING
Institut Bergonie, Bordeaux
WITHDRAWN
Advent Health, Celebration
RECRUITING
Centre Eugène Marquis, Rennes
RECRUITING
SCRI Oncology Partners, Nashville
WITHDRAWN
Markey Cancer Center, Lexington
RECRUITING
Instituto Valenciano de Oncología (IVO), Valencia
COMPLETED
Indiana University Health Hospital, Indianapolis
WITHDRAWN
Barbara Ann Karmanos Cancer Institute, Detroit
RECRUITING
University of Arkansas for Medical Sciences, Little Rock
RECRUITING
Stephenson Cancer Center, Oklahoma City
RECRUITING
MD Anderson, Houston
RECRUITING
Next Oncology, San Antonio
COMPLETED
Honor Health Research Institute, Scottsdale
RECRUITING
City of Hope, Duarte
WITHDRAWN
Providence Medical Group, Santa Rosa
RECRUITING
Swedish Cancer Institute, Seattle
RECRUITING
Dana Farber Cancer Institute, Boston
RECRUITING
LifeSpan - Brown University, Providence
RECRUITING
The Kinghorn Cancer Centre, St Vincent's Health Network Sydney, Darlinghurst
RECRUITING
Southern Oncology Clinical Research Unit, Bedford Park
RECRUITING
Sevrance Hospital, Seoul
RECRUITING
Asan Medical Center, Seoul
RECRUITING
Vall Hebron Institute of Oncology, Barcelona
Lead Sponsor
IDEAYA Biosciences
INDUSTRY